来自专业的译者、企业、网页和免费的翻译库。
til intravenous anvendelse.
for intravenous use.
最后更新： 2011-10-23
使用频率： 4
质量：
警告：此对齐可能有误。
如果您觉得是这样，请将其删除。
busulfan (intravenous use)
busulfan (intravenous use)
最后更新： 2011-10-23
使用频率： 1
质量：
警告：此对齐可能有误。
如果您觉得是这样，请将其删除。
subkutan eller intravenous anvendelse
subcutaneous or intravenous use
最后更新： 2012-04-11
使用频率： 2
质量：
intravenous conditioning treatment prior to hematopoietic progenitor cell transplantation
intravenous conditioning treatment prior to hematopoietic progenitor cell transplantation
最后更新： 2011-10-23
使用频率： 1
质量：
警告：此对齐可能有误。
如果您觉得是这样，请将其删除。
guidelines note for guidance on the clinical investigation of human anti- d immunoglobulin for intravenous and/ or intramuscular use
emea/cpmp/bpwg/575/99
最后更新： 2011-10-23
使用频率： 1
质量：
警告：此对齐可能有误。
如果您觉得是这样，请将其删除。
vigtige oplysninger om nogle af indholdsstofferne i cerezyme dette lægemiddel indeholder natrium og gives i 0, 9% natriumklorid intravenous opløsning (se pkt.6. 6) .
important information about some of the ingredients of cerezyme this medicinal product contains sodium and is administered in 0.9% sodium chloride intravenous solution.
最后更新： 2008-03-04
使用频率： 2
质量：
警告：此对齐可能有误。
如果您觉得是这样，请将其删除。
guidelines note for guidance on the clinical investigation of human anti-d immunoglobulin for intravenous and/or intramuscular use note for guidance on the clinical investigation of human normal immunoglobulin for intravenous administration (ivig) core spc for human and anti-d immunoglobulin for intravenous and/or intramuscular use core spc for human normal immunoglobulin for intravenous administration (ivig) core spc for human plasma derived and recombinant coagulation factor viii products core spc for human plasma derived and recombinant coagulation factor ix products note for guidance on the clinical investigation of human plasma derived factor viii and ix products note for guidance on the clinical investigation of recombinant factor viii and ix products
note for guidance on the clinical investigation of human anti-d immunoglobulin for intravenous and/or intramuscular use adopted june 2000 note for guidance on the clinical investigation of human normal immunoglobulin for intravenous administration (ivig) adopted june 2000 core spc for human and anti-d immunoglobulin for intravenous and/or intramuscular use adopted june 2000 core spc for human normal immunoglobulin for intravenous administration (ivig) adopted june 2000 core spc for human plasma derived and recombinant coagulation factor viii products adopted june 2000 core spc for human plasma derived and recombinant coagulation factor ix products adopted june 2000 note for guidance on the clinical investigation of human plasma derived factor viii and ix products adopted october 2000 note for guidance on the clinical investigation of recombinant factor viii and ix products adopted october 2000
最后更新： 2008-03-04
使用频率： 1
质量：
警告：此对齐可能有误。
如果您觉得是这样，请将其删除。